news

Oct 10, 2024
Oct 8, 2024
Oct 2, 2024
Linkedin-in

Home

introduction
Solutions
Pipeline

Future-Defining SolutionsPatient-Centered Medicine

Pioneering innovative oral therapies to enhance patient health

About Lipocine

Favorable benefit-risk profileAddressing Unmet Needs

Our drug candidates represent enablement of differentiated, patient friendly oral delivery options for favorable benefit to risk profile which target large addressable markets with significant unmet medical needs. 

Pipeline & Product

Feel better faster Maternal Mental Health

LPCN 1154 (BRLIZIO) is under development for postpartum depression (PPD) treatment targeting Rapid Relief with 48-hour dosing schedule.

LPCN 1154 (BRLIZIO)

Convenient Oral Testosterone TLANDO®

TLANDO®, an oral testosterone replacement therapy was developed with patients in mind. Providing the CONVENIENCE and SIMPLICITY of oral dosing

Learn More

Endogenous NASLPCN 2101

An oral neuroactive steroid is developed for drug resistant epilepsy patients and women with epilepsy. Targeting stable seizure control and a superior benefit-to-risk ratio over currently approved AEDs.
Learn More

Prevention of Preterm BirthLPCN 1107

An oral 17-HPC is developed for a new mother with a history of preterm birth. Targeting to be the new standard of care for the prevention of preterm birth.

Learn More

Effective oral deliveryLip’ral

Innovative drug delivery technology enables convenient oral favorable benefit to risk profile therapy option

Learn More
Pipeline & Product
Presentations
Press Releases
Partnering

news

Oct 10, 2024
Oct 8, 2024
Oct 2, 2024

Products & Pipeline

Lipcoine pipeline & product are built upon its technology platform enabling differentiated products targeting significant unmet medical needs in large addressable markets.

With current drug candidates in development and candidates open for partnering, we focus on targeting significant unmet medical needs in large addressable markets.

Product

TLANDO offers the simplicity and convenience of oral dosing for TRT.

Testosterone replacement therapy
Visit TLANDO website

Pipeline Candidates

LPCN 1154

Treatment of Postpartum depression

LPCN 2101

Drug Resistant Epilepsy (DRE)

LPCN 2401

Obesity Management – adjunct to GLP-1

LPCN 1148

Treatment of Liver cirrhosis

LPCN 1107

Prevention of recurrent pre-term birth

LPCN 2203

Treatment of Essential tremor

Focus on enhancing health

We are pioneers of developing innovative drug products targeting significant unmet medical needs.